Medicover AB (publ) (MCOV-B) — Capital Reinvestment Ratio

Latest as of September 2025: 0.53x

Medicover AB (publ) (MCOV-B) has a Capital Reinvestment Ratio of 0.53x as of September 2025, meaning it reinvests 1% of its operating cash flow (Skr980.72 Million) in capital expenditures (Skr523.32 Million). See Medicover AB (publ) free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.53x
Capex / Operating Cash Flow

Operating Cash Flow

Skr980.72 Million
SEK

Capital Expenditures

Skr523.32 Million
SEK

Data as of

Sep 2025
Most recent filing

Medicover AB (publ) Capital Reinvestment Ratio (2005–2024)

This chart tracks Medicover AB (publ)'s Capital Reinvestment Ratio across 12 annual periods.

Annual Capital Reinvestment Ratio for Medicover AB (publ) (2005–2024)

Year-by-year Capital Reinvestment Ratio for Medicover AB (publ) from 2005 to 2024. For live market cap and broader valuation context, see market value of Medicover AB (publ).

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2024 0.47x Skr261.90 Million Skr122.30 Million ▼ -13.4%
2023 0.54x Skr205.00 Million Skr110.50 Million ▼ -34.7%
2022 0.83x Skr170.20 Million Skr140.60 Million ▲ +75.2%
2021 0.47x Skr216.70 Million Skr102.20 Million ▲ +1.5%
2020 0.46x Skr156.00 Million Skr72.50 Million ▼ -35.8%
2019 0.72x Skr87.30 Million Skr63.20 Million ▼ -21.6%
2018 0.92x Skr44.40 Million Skr41.00 Million ▲ +58.0%
2017 0.58x Skr50.30 Million Skr29.40 Million ▼ -72.1%
2016 2.10x Skr25.90 Million Skr54.30 Million ▲ +95.4%
2015 1.07x Skr28.70 Million Skr30.80 Million ▼ -1.3%
2014 1.09x Skr21.70 Million Skr23.60 Million ▲ +10.1%
2005 0.99x Skr4.91 Million Skr4.85 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow